Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by topic
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by topic
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
Archive
Volume 8, Issue 1
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Responses
Article
metrics
Alerts
PDF
Oncolytic and local immunotherapy
Original research
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
Online download statistics by month:
Online download statistics by month: May 2020 to December 2020
Abstract
Full
Pdf
May 2020
132
132
56
Jun 2020
174
174
176
Jul 2020
59
59
12
Aug 2020
82
83
24
Sep 2020
102
102
25
Oct 2020
63
63
17
Nov 2020
73
73
21
Dec 2020
78
78
16
Total
763
764
347
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF